Mycoplasma gallisepticum formulation

Details Mycoplasma gallisepticum formulation Mycoplasma gallisepticum formulation

2007-05-15

2007-05-15

Zeman, Robert A. (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S184100, C424S234100, C435S243000, C435S252100

Reexamination Certificate

active

10194180

ABSTRACT:
The present invention provides a protective formulation that prevents virulentMycoplasma gallisepticuminfection in birds of the order Galliformes. The formulation comprises a protective amount of live MG strain K5054 or derivatives thereof in a pharmaceutically acceptable carrier. A vaccine that prevents virulentMycoplasma gallisepticuminfection in birds of the order Galliformes is also presented. Methods for administering the formulation and vaccine are also presented.

REFERENCES:
patent: 5004607 (1991-04-01), Ragland et al.
patent: 5064647 (1991-11-01), Storm
patent: 5489430 (1996-02-01), Saito et al.
patent: 5621076 (1997-04-01), Kodama et al.
patent: 5766594 (1998-06-01), Kodama et al.
patent: 5914113 (1999-06-01), Schrier
patent: 6086892 (2000-07-01), Cook
patent: 6270770 (2001-08-01), Schrier et al.
patent: 0 307 976 (1989-03-01), None
patent: 0 603 406 (1994-06-01), None
patent: 0 692 532 (1996-01-01), None
patent: 1137306 (1968-12-01), None
patent: 52 134019 (1977-11-01), None
patent: 07 133295 (1995-05-01), None
patent: 07 228542 (1995-08-01), None
Greenspan et al. (Nature Biotechnology 7: 936-937, 1999).
Colman, Res. Immunology, Jan. 1994, vol. 145, pp. 33-36; e.g. p. 33, col. 2.
Marois, C., et al., “Molecular Differentiation ofMycoplasma gallisepticumandMycoplasma imitansStrains by Pulsed-Field Gel Electrophoresis and Random Amplified Polymorphic DNA,”J. Vet. Med. B48:695-703, 2001.
Whithear, K.G., “Control of Avian Mycoplasmoses by Vaccination,”Rev. Sci. Tech. Off. Int. Eipz.15(4):1527-1553, 1996.

Affiliated with

Also associated with

Rating

Mycoplasma gallisepticum formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mycoplasma gallisepticum formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycoplasma gallisepticum formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3738700